Materials and Methods The purpose of this narrative review is to synthesize the current theoretical and empirical evidence on the role of glucagon-like peptide-1 receptor agonists in mood disorders, with a particular focus on their impact on insulin resistance and affective symptoms
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial
The Alliance for Patient Access, the American Diabetes Association and the Obesity Action Coalition hosted the discussion and said that one in four adults in Massachusetts live with obesity
The DELIVER trial randomized 6,263 patients with symptomatic HF, 74% of whom had NYHA class II symptoms, either with HF with moderately reduced ejection fraction (HFmrEF
Weekly consistency matters more than day optimization Choose your injection day and stick with it
Min SH, Yoon JH, Moon SJ, Hahn S, Cho YM (2018) Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis